420Other non-current assets:Funds in respect of employees rights upon retirement
215Deferred issuance costs
25Total other non-current assets
$10,465 March 31,
2011LIABILITIES AND EQUITYCurrent liabilities:Current maturities of long-term loans
$94Accounts payable and accruals:Trade
2,217Advanced payment from customers
25Total current liabilities
3,441Long-term liabilityLiability for employees rights upon retirement
270Total long-term liabilities
270Commitments and contingent liabilities -Total liabilities
3,711Equity:Common stock, par value $0.0001 per share; 125,000,000 shares authorized;
68,178,946 shares issued and outstanding at March 31, 2012
and December 31, 2011.
7Additional paid-in capital
6,754Total liabilities and equity
$10,465(1) All 2012 financial information is derived from the Company's 2012 unaudited financial statements and all 2011 financial information is derived from the Company's 2011 audited financial statements, as disclosed in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission.
About MGuard™ Coronary StentMGuard™ presents a novel combination of a coronary stent merged with an embolic protection specifically designed for acute MI patients. The embolic protection is comprised of an ultra-thin polymer micron net that wraps the stent. The MGuard͐
|SOURCE InspireMD, Inc.|
Copyright©2010 PR Newswire.
All rights reserved